BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK, Lewis VO, Ma J, Stafford RJ, Tari AM, Hortobagyi GN, Ueno NT. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009;10:606-614. [PMID: 19482249 DOI: 10.1016/s1470-2045(09)70088-9] [Cited by in Crossref: 99] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Bezerra ROF, Recchimuzzi DZ, Dos Santos Mota MM, Garcia MRT, de Menezes MR, Mazo PE, Cerri GG. Whole-Body Magnetic Resonance Imaging in the Oncology Setting: An Overview and Update on Recent Advances. J Comput Assist Tomogr 2019;43:66-75. [PMID: 30015799 DOI: 10.1097/RCT.0000000000000772] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Liu F, Dong J, Shen Y, Yun C, Wang R, Wang G, Tan J, Wang T, Yao Q, Wang B, Li L, Mi J, Zhou D, Xiong F. Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies. Front Oncol 2021;11:736654. [PMID: 34671558 DOI: 10.3389/fonc.2021.736654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 You S, Kim TH, Kang DK, Park KJ, An YS, Sun JS. Usefulness of Staging Chest CT in Breast Cancer: Evaluating Diagnostic Yield of Chest CT According to the Molecular Subtype and Clinical Stage. J Clin Med 2021;10:906. [PMID: 33668933 DOI: 10.3390/jcm10050906] [Reference Citation Analysis]
4 Suh HJ, Choi JS, Ko K. Extra-mammary findings detected on breast magnetic resonance imaging: a pictorial essay. Korean J Radiol 2014;15:423-9. [PMID: 25053900 DOI: 10.3348/kjr.2014.15.4.423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Doré-Savard L, Otis V, Belleville K, Lemire M, Archambault M, Tremblay L, Beaudoin JF, Beaudet N, Lecomte R, Lepage M, Gendron L, Sarret P. Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain. PLoS One 2010;5:e13774. [PMID: 21048940 DOI: 10.1371/journal.pone.0013774] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
6 Marazzi F, Orlandi A, Manfrida S, Masiello V, Di Leone A, Massaccesi M, Moschella F, Franceschini G, Bria E, Gambacorta MA, Masetti R, Tortora G, Valentini V. Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians. Cancers (Basel) 2020;12:E2390. [PMID: 32846945 DOI: 10.3390/cancers12092390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Doré-Savard L, Beaudet N, Tremblay L, Xiao Y, Lepage M, Sarret P. A micro-imaging study linking bone cancer pain with tumor growth and bone resorption in a rat model. Clin Exp Metastasis 2013;30:225-36. [PMID: 22956259 DOI: 10.1007/s10585-012-9530-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
8 Xu B, Hu X, Jiang Z, Li H, Chen J, Cui S, Li Q, Liao N, Liu D, Liu J, Lu J, Shen K, Sun T, Teng Y, Tong Z, Wang S, Wang X, Wang X, Wang Y, Wu J, Yuan P, Zhang P, Zhang Q, Zheng H, Pang D, Ren G, Shao Z, Shen Z, Song E, Song S. National consensus in China on diagnosis and treatment of patients with advanced breast cancer. Ann Transl Med 2015;3:242. [PMID: 26605288 DOI: 10.3978/j.issn.2305-5839.2015.09.47] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
9 Costelloe CM, Chuang HH, Chasen BA, Pan T, Fox PS, Bassett RL, Madewell JE. Bone Windows for Distinguishing Malignant from Benign Primary Bone Tumors on FDG PET/CT. J Cancer 2013;4:524-30. [PMID: 23983816 DOI: 10.7150/jca.6259] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
10 Saini VK, Mammoottil AE, Ora M, Gambhir S, Nazar AH. Contiguous Multilevel Vertebral Metastasis in Carcinoma Breast Mimicking Spondylodiscitis. Indian J Nucl Med 2021;36:316-8. [PMID: 34658560 DOI: 10.4103/ijnm.ijnm_30_21] [Reference Citation Analysis]
11 Park SM, Park JW, Lee HJ, Choi JY, Yoo HJ, Lee CK, Chang BS, Kim H. Diagnostic Value of Technetium-99m Bone Scintigraphy in the Detection of Cervical Spine Metastases in Oncological Patients. Spine (Phila Pa 1976) 2017;42:1699-705. [PMID: 28368988 DOI: 10.1097/BRS.0000000000002183] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Pagnotti GM, Trivedi T, Mohammad KS. Translational Strategies to Target Metastatic Bone Disease. Cells 2022;11:1309. [PMID: 35455987 DOI: 10.3390/cells11081309] [Reference Citation Analysis]
13 Heindel W, Gübitz R, Vieth V, Weckesser M, Schober O, Schäfers M. The diagnostic imaging of bone metastases. Dtsch Arztebl Int 2014;111:741-7. [PMID: 25412631 DOI: 10.3238/arztebl.2014.0741] [Cited by in Crossref: 19] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
14 Liu GY, Xia WX, Bi ZF, Lu N, Li WZ, Bei WX, Liang H, Xie JZ, Liu YM, Yao HR, Xiang YQ. Plasma Circulating Tumor Epstein-Barr Virus for the Surveillance of Cancer Progression in Bone-Only Metastatic Nasopharyngeal Carcinoma. Front Oncol 2022;12:860700. [PMID: 35756638 DOI: 10.3389/fonc.2022.860700] [Reference Citation Analysis]
15 Rizzoli R, Body JJ, Brandi ML, Cannata-Andia J, Chappard D, El Maghraoui A, Glüer CC, Kendler D, Napoli N, Papaioannou A. Cancer-associated bone disease. Osteoporos Int. 2013;24:2929-2953. [PMID: 24146095 DOI: 10.1007/s00198-013-2530-3] [Cited by in Crossref: 81] [Cited by in F6Publishing: 68] [Article Influence: 9.0] [Reference Citation Analysis]
16 Hahn S, Heusner T, Kümmel S, Köninger A, Nagarajah J, Müller S, Boy C, Forsting M, Bockisch A, Antoch G, Stahl A. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer. Acta Radiol 2011;52:1009-14. [PMID: 21969709 DOI: 10.1258/ar.2011.100507] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
17 Li Q, Chen Z, Zhao Y, Li X, Pan H, Xia T, Chen L, Xu Z, Zhou W, Liu X. Risk of metastasis among rib abnormalities on bone scans in breast cancer patients. Sci Rep 2015;5:9587. [PMID: 25939860 DOI: 10.1038/srep09587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
18 Moon JB, Yoo SW, Lee C, Kim DY, Pyo A, Kwon SY. Multimodal Imaging-Based Potential Visualization of the Tumor Microenvironment in Bone Metastasis. Cells 2021;10:2877. [PMID: 34831100 DOI: 10.3390/cells10112877] [Reference Citation Analysis]
19 Baltasar Sánchez A, González-Sistal A. Design of a Web-tool for diagnostic clinical trials handling medical imaging research. J Digit Imaging 2011;24:196-202. [PMID: 20517632 DOI: 10.1007/s10278-010-9304-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Hart NH, Galvão DA, Saunders C, Taaffe DR, Feeney KT, Spry NA, Tsoi D, Martin H, Chee R, Clay T, Redfern AD, Newton RU. Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine. Trials 2018;19:695. [PMID: 30572928 DOI: 10.1186/s13063-018-3091-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
21 Koleva-Kolarova RG, Greuter MJ, van Kruchten M, Vermeulen KM, Feenstra T, Buskens E, Glaudemans AW, de Vries EF, de Vries EG, Hospers GA, de Bock GH. The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients. Br J Cancer 2015;112:1617-25. [PMID: 25880006 DOI: 10.1038/bjc.2015.138] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
22 Balci A, Koc P, Komek H. Bone Scan or 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography; Which Modality Better Shows Bone Metastases of Breast Cancer? Breast Care. 2012;7:389-393. [PMID: 24647778 DOI: 10.1159/000341559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
23 Condeelis J, Weissleder R. In vivo imaging in cancer. Cold Spring Harb Perspect Biol 2010;2:a003848. [PMID: 20861158 DOI: 10.1101/cshperspect.a003848] [Cited by in Crossref: 159] [Cited by in F6Publishing: 135] [Article Influence: 13.3] [Reference Citation Analysis]
24 Goyal N, Kalra M, Soni A, Baweja P, Ghonghe NP. Multi-modality imaging approach to bone tumors - State-of-the art. J Clin Orthop Trauma 2019;10:687-701. [PMID: 31316240 DOI: 10.1016/j.jcot.2019.05.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
25 Pesapane F, Downey K, Rotili A, Cassano E, Koh DM. Imaging diagnosis of metastatic breast cancer. Insights Imaging 2020;11:79. [PMID: 32548731 DOI: 10.1186/s13244-020-00885-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
26 Chen HY, Ma XM, Bai YR. Radiographic characteristics of bone metastases from hepatocellular carcinoma. Contemp Oncol (Pozn) 2012;16:424-31. [PMID: 23788922 DOI: 10.5114/wo.2012.31773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Mi B, Yu C, Pan D, Yang M, Wan W, Niu G, Chen X. Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases. Theranostics 2015;5:1115-21. [PMID: 26199649 DOI: 10.7150/thno.12938] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
28 Ju DG, Yurter A, Gokaslan ZL, Sciubba DM. Diagnosis and surgical management of breast cancer metastatic to the spine. World J Clin Oncol 2014; 5(3): 263-271 [PMID: 25114843 DOI: 10.5306/wjco.v5.i3.263] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
29 Agarwal MG, Nayak P. Management of skeletal metastases: An orthopaedic surgeon's guide. Indian J Orthop 2015;49:83-100. [PMID: 25593359 DOI: 10.4103/0019-5413.143915] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
30 Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, Pomper MG, Fisher PB. Detecting Tumor Metastases: The Road to Therapy Starts Here. Adv Cancer Res 2016;132:1-44. [PMID: 27613128 DOI: 10.1016/bs.acr.2016.07.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
31 Lee AY, Navarro R, Busby LP, Greenwood HI, Bucknor MD, Ray KM, Joe BN. Characterization of Metastatic Sternal Lesions on Dynamic Contrast-Enhanced Breast MRI in Women with Invasive Breast Cancer. Acad Radiol 2019;26:1358-62. [PMID: 30527457 DOI: 10.1016/j.acra.2018.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Gao Y, Li F, Zhou H, Yang Y, Wu R, Chen Y, Li W, Li Y, Xu X, Ke C, Pei Z. Down-regulation of MRPS23 inhibits rat breast cancer proliferation and metastasis. Oncotarget. 2017;8:71772-71781. [PMID: 29069745 DOI: 10.18632/oncotarget.17888] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
33 Idota A, Sawaki M, Yoshimura A, Hattori M, Inaba Y, Oze I, Kikumori T, Kodera Y, Iwata H. Bone Scan Index predicts skeletal-related events in patients with metastatic breast cancer. Springerplus 2016;5:1095. [PMID: 27468396 DOI: 10.1186/s40064-016-2741-0] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
34 Niikura N, Costelloe CM, Madewell JE, Hayashi N, Yu TK, Liu J, Palla SL, Tokuda Y, Theriault RL, Hortobagyi GN. FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer. Oncologist. 2011;16:1111-1119. [PMID: 21765193 DOI: 10.1634/theoncologist.2011-0089] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
35 Ueno NT, Tahara RK, Fujii T, Reuben JM, Gao H, Saigal B, Lucci A, Iwase T, Ibrahim NK, Damodaran S, Shen Y, Liu DD, Hortobagyi GN, Tripathy D, Lim B, Chasen BA. Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer. Cancer Med 2020;9:1025-32. [PMID: 31849202 DOI: 10.1002/cam4.2780] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
36 Husseini JS, Balza R, Evangelista L, Cañamaque LG, Catalano OA. PET/MR for evaluation of musculoskeletal malignancies. Clin Transl Imaging. [DOI: 10.1007/s40336-021-00470-9] [Reference Citation Analysis]
37 Orcajo-Rincon J, Muñoz-Langa J, Sepúlveda-Sánchez JM, Fernández-Pérez GC, Martínez M, Noriega-Álvarez E, Sanz-Viedma S, Vilanova JC, Luna A. Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer. Clin Transl Oncol 2022;24:1290-310. [PMID: 35152355 DOI: 10.1007/s12094-022-02784-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Cochet A, Dygai-Cochet I, Riedinger JM, Humbert O, Berriolo-Riedinger A, Toubeau M, Guiu S, Coutant C, Coudert B, Fumoleau P. 18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations. Eur J Nucl Med Mol Imaging. 2014;41:428-437. [PMID: 24196916 DOI: 10.1007/s00259-013-2595-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
39 O’Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metastasis: An update. World J Radiol 2015; 7(8): 202-211 [PMID: 26339464 DOI: 10.4329/wjr.v7.i8.202] [Cited by in CrossRef: 155] [Cited by in F6Publishing: 118] [Article Influence: 22.1] [Reference Citation Analysis]
40 Al-Ogaili Z, Troedson R. Novel CT and scintigraphic findings of bone metastasis from invasive lobular breast cancer. J Med Imaging Radiat Oncol 2016;60:47-53. [PMID: 26549329 DOI: 10.1111/1754-9485.12415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Manapragada PP. Molecular Imaging in Management of Breast Cancer. Semin Roentgenol 2018;53:301-10. [PMID: 30449348 DOI: 10.1053/j.ro.2018.08.007] [Reference Citation Analysis]
42 Catalano OA, Nicolai E, Rosen BR, Luongo A, Catalano M, Iannace C, Guimaraes A, Vangel MG, Mahmood U, Soricelli A. Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients. Br J Cancer. 2015;112:1452-1460. [PMID: 25871331 DOI: 10.1038/bjc.2015.112] [Cited by in Crossref: 67] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
43 Costelloe CM, Kundra V, Ma J, Chasen BA, Rohren EM, Bassett RL Jr, Madewell JE. Fast Dixon whole-body MRI for detecting distant cancer metastasis: a preliminary clinical study. J Magn Reson Imaging 2012;35:399-408. [PMID: 21990095 DOI: 10.1002/jmri.22815] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
44 Kong Y, Ma XW, Zhang QQ, Zhao Y, Feng HL. Gastrointestinal stromal tumor with multisegmental spinal metastases as first presentation: A case report and review of the literature. World J Clin Cases 2021; 9(6): 1490-1498 [PMID: 33644220 DOI: 10.12998/wjcc.v9.i6.1490] [Reference Citation Analysis]
45 Nervo A, Ragni A, Retta F, Gallo M, Piovesan A, Liberini V, Gatti M, Ricardi U, Deandreis D, Arvat E. Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues. J Endocrinol Invest 2021;44:403-19. [PMID: 32743746 DOI: 10.1007/s40618-020-01374-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
46 Liu X, Peng Y, Wang J. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers. Biosci Rep 2020;40:BSR20201053. [PMID: 32412047 DOI: 10.1042/BSR20201053] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
47 Shenoy P, Kuo A, Vetter I, Smith MT. Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods. Front Pharmacol 2017;8:442. [PMID: 28729837 DOI: 10.3389/fphar.2017.00442] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
48 Chang CY, Gill CM, Joseph Simeone F, Taneja AK, Huang AJ, Torriani M, Bredella MA. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases. Acta Radiol 2016;57:58-65. [PMID: 25533313 DOI: 10.1177/0284185114564438] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
49 Husseini JS, Amorim BJ, Torrado-Carvajal A, Prabhu V, Groshar D, Umutlu L, Herrmann K, Cañamaque LG, Garzón JRG, Palmer WE, Heidari P, Shih TT, Sosna J, Matushita C, Cerci J, Queiroz M, Muglia VF, Nogueira-Barbosa MH, Borra RJH, Kwee TC, Glaudemans AWJM, Evangelista L, Salvatore M, Cuocolo A, Soricelli A, Herold C, Laghi A, Mayerhoefer M, Mahmood U, Catana C, Daldrup-Link HE, Rosen B, Catalano OA. An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases. Eur J Nucl Med Mol Imaging 2021;48:1522-37. [PMID: 33619599 DOI: 10.1007/s00259-021-05198-2] [Reference Citation Analysis]
50 Polednak AP. Increase in Distant Stage Breast Cancer Incidence Rates in US Women Aged 25-49 Years, 2000-2011: The Stage Migration Hypothesis. J Cancer Epidemiol 2015;2015:710106. [PMID: 25649489 DOI: 10.1155/2015/710106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
51 Yang X, Zhu CH, Cao R, Hao J, Wu XZ. Sublingual Nodules: Diagnostic Markers of Metastatic Breast Cancer. Chin J Integr Med 2018;24:741-5. [PMID: 29667148 DOI: 10.1007/s11655-018-2837-1] [Reference Citation Analysis]
52 Penet MF, Chen Z, Bhujwalla ZM. MRI of metastasis-permissive microenvironments. Future Oncol 2011;7:1269-84. [PMID: 22044202 DOI: 10.2217/fon.11.114] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]